Federal funding is a huge boon for companies, universities, and research institutions conducting innovative research. However, it comes attached with
Continue Reading Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act
In April of 2021, we provided a three-part series relating to the IP and Competitive Landscape for the mRNA market.
Continue Reading mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook
Following the successful development (and financial success) of its mRNA vaccine, biotech company Moderna is now looking to expand into
Continue Reading Moderna’s Next Steps: Spikevax Today, Gene Editing Tomorrow